Emergent Biosolutions Inc. sell JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€1.86
Target price
20.11.24
-
Performance (%)
135.05%
Price
24.05.24
€4.38
Summary
This prediction is currently active. The SELL prediction by JPMorgan_Chase___Co_ for Emergent Biosolutions Inc. is trending in the completely wrong direction and now has a performance of 135.05%. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Emergent Biosolutions Inc. | -14.305% | -14.305% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat